Brazil DNA Diagnostics Market Size & Outlook, 2030

Revenue, 2024 (US$M)

$0.0

Forecast, 2030 (US$M)

$0.0

CAGR, 2025 - 2030

Report Coverage

Brazil

Brazil dna diagnostics market, 2018-2030 (US$M)

Related Markets

Global DNA Diagnostics Industry Outlook

North America DNA Diagnostics Market Outlook

Europe DNA Diagnostics Market Outlook

Asia Pacific DNA Diagnostics Market Outlook

Latin America DNA Diagnostics Market Outlook

MEA DNA Diagnostics Market Outlook

Brazil dna diagnostics market highlights

The Brazil dna diagnostics market generated a revenue of USD 228.3 million in 2023 and is expected to reach USD 317.9 million by 2030.
The Brazil market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2023.
NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.

Dna diagnostics market data book summary

Market revenue in 2023	USD 228.3 million
Market revenue in 2030	USD 317.9 million
Growth rate	4.8% (CAGR from 2023 to 2030)
Largest segment	Pcr-based diagnostics
Fastest growing segment	NGS DNA Diagnosis
Historical data	2018 - 2022
Base year	2023
Forecast period	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics
Key market players worldwide	GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc

Other key industry trends

In terms of revenue, Brazil accounted for 2.1% of the global dna diagnostics market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Latin America, Brazil dna diagnostics market is projected to lead the regional market in terms of revenue in 2030.
Brazil is the fastest growing regional market in Latin America and is projected to reach USD 317.9 million by 2030.

Key Regions: U.S. , UK , Japan , Canada , Germany

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

DNA Diagnostics Market Scope

Dna diagnostics market segmentation & scope

Technology

PCR-based Diagnostics

NGS DNA Diagnosis

In-Situ Hybridization Diagnostics

Microarrays-based Diagnostics

Application

Cancer Genetics Tests

Infectious Diseases DNA Testing

HBV Diagnostic

HCV Diagnostic

HIV Diagnostic

TB Diagnostic

CT/NG Diagnostic

HPV Diagnostic

MRSA Diagnostic

Others Infectious Disease Diagnostic

Newborn Genetic Screening

Preimplantation & Reproductive Diagnosis

Non-Infectious Diseases DNA Testing

Cardiovascular Diseases

CNS & PNS Related

Skeletal, Connective, Ectodermal & Dermal DNA Testing

Lung, Kidney, Liver & GT Related

Sensory Diseases

Prenatal DNA Carrier Screening

Pharmacogenomics/Drug Metabolism

Hematology & Immunology/Identity Diagnostics & Forensics

Other Applications

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Mexico

Germany

Spain

France

Italy

Denmark

Sweden

Norway

Japan

China

India

South Korea

Australia

Thailand

Brazil

Argentina

South Africa

Saudi Arabia

UAE

Kuwait

DNA Diagnostics Market Companies

Name	Profile	# Employees	HQ	Website

Brazil dna diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.

Pcr-based diagnostics was the largest segment with a revenue share of 49.63% in 2024. Horizon Databook has segmented the Brazil dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.

The growth of DNA diagnostics market in Brazil is primarily driven by the increasing prevalence of genetic disorders and infectious diseases, coupled with government investments in healthcare infrastructure and genomic research.

In addition, growing awareness about personalized medicine and the expansion of private healthcare facilities contribute to market growth. Brazil has the largest population in Latin America. Thus, there is a high incidence of cancer in the country. Brazil is witnessing a significant change in its epidemiological landscape as the burden of Noncommunicable Diseases (NCDs)—like cancer—begins to rapidly surpass that of infectious diseases due to increasing incidence and prevalence.

Meanwhile, the country is undergoing a difficult economic phase that has severely limited financial resources. With a focus on primary care, the public healthcare system offers an opportunity to provide integrated and high-quality care for the increasing number of cancer survivors, while remaining affordable.

Reasons to subscribe to Brazil dna diagnostics market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil dna diagnostics market databook

Our clientele includes a mix of dna diagnostics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list